These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 299883)
1. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. Röllinghoff M; Starzinski-Powitz A; Pfizenmaier K; Wagner H J Exp Med; 1977 Feb; 145(2):455-9. PubMed ID: 299883 [TBL] [Abstract][Full Text] [Related]
2. In vivo sensitization of T cells to hapten-conjugated syngeneic structures of major histocompatibility complex. I. Effect of in vitro culture upon generation of cytotoxic T lymphocytes. Starzinski-Powitz A; Pfizenmaier K; Röllinghoff M; Wagner H Eur J Immunol; 1976 Nov; 6(11):799-805. PubMed ID: 1087237 [TBL] [Abstract][Full Text] [Related]
3. Ongoing hapten-specific delayed-type hypersensitivity prevents generation of cytolytic T lymphocytes to the same hapten. Wong HL; Battisto JR Cell Immunol; 1985 Aug; 94(1):205-14. PubMed ID: 3160488 [TBL] [Abstract][Full Text] [Related]
4. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice. Glaser M J Exp Med; 1979 Mar; 149(3):774-9. PubMed ID: 219129 [TBL] [Abstract][Full Text] [Related]
5. During lymphatic regeneration, precursors for major histocompatibility complex-restricted cytotoxic T cells appear before alloreactive precursors. Hurme M; Sihvola M; Bång B J Exp Med; 1982 Jan; 155(1):327-32. PubMed ID: 6976415 [TBL] [Abstract][Full Text] [Related]
6. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes. Pfizenmaier K; Jung H; Starzinski-Powitz A; Röllinghoff M; Wagner H J Immunol; 1977 Sep; 119(3):939-44. PubMed ID: 70478 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocytes induced against allogeneic I-region determinants react with Ia molecules on trinitrophenyl-conjugated syngeneic target cells. Billings P; Burakoff S; Dorf ME; Benacerraf B J Exp Med; 1977 Aug; 146(2):623-8. PubMed ID: 69009 [TBL] [Abstract][Full Text] [Related]
8. Suppressor cells for in vivo cytotoxic responses--regulation of the in vivo activation of cytotoxic T-lymphocytes by suppressive cells. Dröge W; Süssmuth W; Franze R Adv Exp Med Biol; 1979; 114():319-25. PubMed ID: 88878 [TBL] [Abstract][Full Text] [Related]
9. Two distinct suppressor T cells acting in concert cause suppression of cytolytic T lymphocyte (CTL) response to hapten-altered self in vivo. Gautam SC; Beckman KD; Wong HL; Battisto JR J Immunol; 1983 Jun; 130(6):2557-60. PubMed ID: 6222107 [TBL] [Abstract][Full Text] [Related]
10. Immune suppression with supraoptimal doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity to cyclophosphamide. Sy MS; Miller SD; Claman HN J Immunol; 1977 Jul; 119(1):240-4. PubMed ID: 68972 [TBL] [Abstract][Full Text] [Related]
11. T lymphocyte-mediated suppression of myeloma function in vitro. II. Evidence for regulation of hapten-binding myelomas by syngeneic hapten-specific cytolytic T lymphocytes. Abbas AK; Ratnofsky SE; Burakoff SJ J Exp Med; 1980 Aug; 152(2):306-23. PubMed ID: 6156985 [TBL] [Abstract][Full Text] [Related]
12. Suppression of anti-hapten antibody responses by hapten-specific cytolytic T lymphocytes: role of I-A-associated antigen on target B lymphocytes. Moser G; Burakoff SJ; Abbas AK J Immunol; 1982 Jul; 129(1):63-9. PubMed ID: 6177761 [TBL] [Abstract][Full Text] [Related]
13. Induction of I region-restricted hapten-specific cytotoxic T lymphocytes. Wagner H; Starzinski-Powitz A; Jung H; Röllinghoff M J Immunol; 1977 Oct; 119(4):1365-8. PubMed ID: 302282 [TBL] [Abstract][Full Text] [Related]
14. The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro. Varkila K; Hurme M Immunology; 1983 Mar; 48(3):433-8. PubMed ID: 6219062 [TBL] [Abstract][Full Text] [Related]
15. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related]
16. Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self. Vargo PM; Battisto JR J Immunol; 1984 Jun; 132(6):2796-801. PubMed ID: 6233362 [TBL] [Abstract][Full Text] [Related]
17. Pretreatment with minor histocompatibility antigens prevents the development of functional CTL helper cell activity. Hayes RL; Claman HN J Immunol; 1983 Jan; 130(1):56-62. PubMed ID: 6216288 [TBL] [Abstract][Full Text] [Related]
18. Generation of cytotoxic T lymphocytes in vitro. III. Velocity sedimentation studies of the differentiation and fate of effector cells in long-term mixed leukocyte cultures. MacDonald HR; Cerottini JC; Brunner KT J Exp Med; 1974 Dec; 140(6):1511-21. PubMed ID: 4279270 [TBL] [Abstract][Full Text] [Related]
19. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. Mayumi H; Good RA J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528 [TBL] [Abstract][Full Text] [Related]
20. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect. Fujiwara H; Levy RB; Shearer GM J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]